Company: FLYE
Filing Date: 2025-04-22
Form Type: S-1
Source: 0001213900-25-034233
Chunk: 20

Company: Fly-E Group, Inc.
Filing Date: 2025-04-22
Form: S-1
Chunk 20
---
 of capital stock of the Company, subject to certain exceptions. See “Plan of Distribution”.                           |
| Nasdaq listing and symbol |     | Our Common Stock is listed on the Nasdaq Capital Market under the symbol “FLYE”.                                                                 |
| Payment and settlement    |     | We expect to hold the closing of the offering and deliver the securities                                                                         
 comprising the share of Common Stock and accompanying Warrants against payment on or around [●], 2025. The offering will be terminated           
 by [●], 2025, provided that closing of the offering for all of the shares of Common Stock and accompanying Warrants have not occurred            
 by such date, and may be extended by written agreement of us and the Placement Agent for a maximum period of [●] days. We will                   
 deliver all securities to be issued in connection with this offering delivery versus payment or receipt versus payment, as the case may          
 be, upon receipt of investor funds received by us. Accordingly, neither we nor the Placement Agent (as defined below) have made any arrangements 
 to place investor funds in an escrow account or trust account since the Placement Agent will not receive investor funds in connection            
 with the sale of the securities offered hereunder.                                                                                               |

The number of shares of Common Stock to be outstanding after this offering is based on 24,587,500 shares of our Common Stock outstanding as of April 22, 2025 and excludes, as of that date, the following:

| ● | 129,375 shares of Common                                                                        
 Stock issuable upon the exercise of the IPO Representative’s Warrants;                          |
| ● | 72,727,272 shares of Common                                                                     
 Stock underlying the Warrants to be issued in connection with this offering; and                |
| ● | 3,700,000 shares of                                                                             
 Common Stock reserved for future grants of equity-based awards under our equity incentive plan. |

Unless otherwise indicated, this prospectus reflects and assumes no exercise of any of the Warrants.

<div align='center'>10

Risk Factors</div>

An investment in our securities involves a high degree of risk. You should carefully consider the risks and uncertainties described below, as well as the risks set forth under the section titled “Risk Factors” in our 2024 Annual Report and our 2024 Quarterly Reports, which are incorporated by reference herein. You should also refer to the other information contained in this prospectus and the documents incorporated by reference herein, including the section titled “Management’s Discussion and Analysis of Financial Condition